6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
- $503.83 - $555
- Product name: 6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
- CAS: 881040-33-1
- MF: C16H13ClN2O
- MW: 284.74
- EINECS:
- MDL Number:MFCD06653351
- Synonyms:6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE;Imidazo[1,2-a]pyridine-3-carboxaldehyde, 6-chloro-2-(2,4-dimethylphenyl)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 5MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0035492
- Product description6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE 95.00%
- Packaging5MG
- Price$503.83
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM269302
- Product description6-Chloro-2-(2,4-dimethylphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde 95%
- Packaging5g
- Price$525
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11036076
- Product description6-Chloro-2-(2,4-dimethylphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde 95+%
- Packaging5g
- Price$555
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0035492 | 6-CHLORO-2-(2,4-DIMETHYLPHENYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE 95.00% | 5MG | $503.83 | 2021-12-16 | Buy |
Chemenu | CM269302 | 6-Chloro-2-(2,4-dimethylphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde 95% | 5g | $525 | 2021-12-16 | Buy |
Crysdot | CD11036076 | 6-Chloro-2-(2,4-dimethylphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde 95+% | 5g | $555 | 2021-12-16 | Buy |
Properties
Density :1.26±0.1 g/cm3(Predicted)
pka :2.50±0.50(Predicted)
pka :2.50±0.50(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|